Monopar Therapeutics (MNPR) Other Non-Current Assets: 2016-2019
Historic Other Non-Current Assets for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to $122,381.
- Monopar Therapeutics' Other Non-Current Assets was N/A to $68,858 in Q3 2020 from the same period last year, while for Sep 2020 it was $68,858, marking a year-over-year change of. This contributed to the annual value of $122,381 for FY2019, which is 86.18% up from last year.
- According to the latest figures from FY2019, Monopar Therapeutics' Other Non-Current Assets is $122,381, which was up 86.18% from $65,731 recorded in FY2018.
- Over the past 5 years, Monopar Therapeutics' Other Non-Current Assets peaked at $800,393 during FY2016, and registered a low of $65,731 during FY2018.
- Moreover, its 3-year median value for Other Non-Current Assets was $122,381 (2019), whereas its average is $329,381.
- In the last 5 years, Monopar Therapeutics' Other Non-Current Assets tumbled by 91.78% in 2018 and then skyrocketed by 86.18% in 2019.
- Yearly analysis of 4 years shows Monopar Therapeutics' Other Non-Current Assets stood at $800,393 in 2016, then declined by 0.05% to $800,031 in 2017, then tumbled by 91.78% to $65,731 in 2018, then soared by 86.18% to $122,381 in 2019.